A Review of the Studies on Placental Mesenchymal Stem Cells and Their Exosomes Applied to Preeclampsia

Jiali Zhang; Jingjing Sheng; Yuxian Wang; Jian Xu

doi:10.23977/medsc.2024.050211

A Review of the Studies on Placental Mesenchymal Stem Cells and Their Exosomes Applied to Preeclampsia

Download as PDF

DOI: 10.23977/medsc.2024.050211 | Downloads: 7 | Views: 70

Author(s)

Jiali Zhang ¹, Jingjing Sheng ¹, Yuxian Wang ¹, Jian Xu ¹

Affiliation(s)

¹ The Fourth Affiliated Hospital, Zhejiang University, Yiwu, China

Corresponding Author

Jian Xu

ABSTRACT

Preeclampsia (PE) is a complex complication of pregnancy, which is a major cause of maternal and neonatal mortality. Its pathogenesis is closely associated with placental defects, although the specific mechanisms remain unknown, and specific targeted therapeutic interventions are currently unavailable. This article reviews recent domestic and international literature on PE and reveals the differences in placental mesenchymal stem cells (PMSCs) between PE and normal pregnancy groups. PMSCs play a crucial role in intercellular communication, regulating the normal functions of cells and organs, including maintaining a healthy pregnancy. The pathogenesis of PE is intricately linked to PMSCs, and abnormalities in these cells are associated with oxidative stress, inflammation, vascular endothelial damage and placental anomalies. Recent research on exosomes offers the potential for treatment strategies for PE. This article provides a comprehensive overview of the role of PMSCs and their exosomes in the pathogenesis of PE, while also delving into their potential utility in the prognosis and management of this distinctive pregnancy-related ailment presenting invaluable perspectives for forthcoming investigations within this domain of scholarly inquiry.

KEYWORDS

Placental mesenchymal stem cells (PMSCs); exosomes; preeclampsia; microRNAs

CITE THIS PAPER

Jiali Zhang, Jingjing Sheng, Yuxian Wang, Jian Xu, A Review of the Studies on Placental Mesenchymal Stem Cells and Their Exosomes Applied to Preeclampsia. MEDS Clinical Medicine (2024) Vol. 5: 71-77. DOI: http://dx.doi.org/10.23977/medsc.2024.050211.

REFERENCES

[1] Rana S, Lemoine E, Granger JP, et al. Preeclampsia: pathophysiology, challenges, and perspectives[J].Circ Res, 2019,124(7):1094-1112.
[2] Özgen G, Cakmak B D, Özgen L, et al. The role of oligohydramnios and fetal growth restriction in adverse pregnancy outcomes in preeclamptic patients [J]. Ginekologia Polska, 2022, 93(3): 235-241.
[3] Tan L , Chen Z , Sun F ,et al. Placental Trophoblast Specific Overexpression of Chemerin Induces Preeclampsia-like Symptoms[J].Placenta, 2021, 112:e56
[4] Boss A L, Chamley L W, James J L. Placental formation in early pregnancy: how is the centre of the placenta made [J]. Human reproduction update, 2018, 24(6): 750-760.
[5] Turco M Y , Gardner L , Kay R G ,et al. Trophoblast organoids as a model for maternal–fetal interactions during human placentation[J].Nature, 2018, 564(7735):263-267.
[6] Haider S, Meinhardt G, Saleh L, et al. Self-renewing trophoblast organoids recapitulate the developmental program of the early human placenta [J]. Stem cell reports, 2018, 11(2): 537-551.
[7] Perez-Garcia V, Fineberg E, Wilson R, et al. Placentation defects are highly prevalent in embryonic lethal mouse mutants [J]. Nature, 2018, 555(7697): 463-468.
[8] Burton G J, Redman C W, Roberts J M, et al. Pre-eclampsia: pathophysiology and clinical implications[J]. Bmj, 2019, 366.
[9] Lee J M, Jung J, Lee H J, et al. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells [J]. International immunopharmacology, 2012, 13(2): 219-224.
[10] Zhang Y, Zhong Y, Zou L, et al. Significance of placental mesenchymal stem cell in placenta development and implications for preeclampsia[J]. Frontiers in Pharmacology, 2022, 13: 896531.
[11] Javadi M, Rad J S, Farashah M S G, et al. An insight on the role of altered function and expression of exosomes and MicroRNAs in female reproductive diseases [J]. Reproductive Sciences, 2021: 1-13.
[12] Langham MC, Caporale AS, Wehrli FW, Parry S, Schwartz N. Evaluation of Vascular Reactivity of Maternal Vascular Adaptations of Pregnancy With Quantitative MRI: Pilot Study. J Magn Reson Imaging. 2021 Feb; 53(2):447-455. doi: 10.1002/jmri.27342. Epub 2020 Aug 25. PMID: 32841482.
[13] Matsubara K, Matsubara Y, Uchikura Y, et al. Pathophysiology of preeclampsia: the role of exosomes[J]. International Journal of Molecular Sciences, 2021, 22(5): 2572.
[14] Hashimoto A, Sugiura K, Hoshino A. Impact of exosome-mediated feto-maternal interactions on pregnancy maintenance and development of obstetric complications[J]. The journal of biochemistry, 2021, 169(2): 163-171.
[15] Komaki M, Numata Y, Morioka C, et al. Exosomes of human placenta-derived mesenchymal stem cells stimulate angiogenesis [J]. Stem cell research & therapy, 2017, 8(1): 1-12.
[16] Xie Min, Xiong Wei, She Zhou, et al. Immunoregulatory effects of stem cell-derived extracellular vesicles on immune cells [J]. Frontiers in Immunology, 2020, 11: 13.
[17] Stenqvist A C, Nagaeva O, Baranov V, et al. Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus[J]. The Journal of Immunology, 2013, 191(11): 5515-5523.
[18] Devor A S M .Trimester-specific plasma exosome microRNA expression profiles in preeclampsia[J].The journal of maternal-fetal & neonatal medicine, 2020, 33(13a18).
[19] Li H, Ouyang Y, Sadovsky E, et al. Unique microRNA signals in plasma exosomes from pregnancies complicated by preeclampsia[J]. Hypertension, 2020, 75(3): 762-771.
[20] Awamleh Z, Gloor G B, Han V K M. Placental microRNAs in pregnancies with early onset intrauterine growth restriction and preeclampsia: potential impact on gene expression and pathophysiology[J]. BMC Medical Genomics, 2019, 12: 1-10.
[21] Salomon C, Guanzon D, Scholz-Romero K, et al. Placental exosomes as early biomarker of preeclampsia: potential role of exosomal microRNAs across gestation[J]. The Journal of Clinical Endocrinology & Metabolism, 2017, 102(9): 3182-3194.
[22] Peñailillo R, Acuña-Gallardo S, García F, et al. Mesenchymal Stem Cells-Induced Trophoblast Invasion Is Reduced in Patients with a Previous History of Preeclampsia[J]. International Journal of Molecular Sciences, 2022, 23(16): 9071.
[23] Qi J, Wu B, Chen X, et al. Diagnostic biomolecules and combination therapy for pre-eclampsia[J]. Reproductive Biology and Endocrinology, 2022, 20(1): 136.
[24] Rostom D M, Attia N, Khalifa H M, et al. The therapeutic potential of extracellular vesicles versus mesenchymal stem cells in liver damage [J]. Tissue Engineering and Regenerative Medicine, 2020, 17: 537-552.
[25] Huang Q, Gong M, Tan T, et al. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-18b-3p inhibits the occurrence of preeclampsia by targeting LEP[J]. Nanoscale Research Letters, 2021, 16: 1-13.
[26] Zheng S, Shi A, Hill S, et al. Decidual mesenchymal stem/stromal cell-derived extracellular vesicles ameliorate endothelial cell proliferation, inflammation, and oxidative stress in a cell culture model of preeclampsia [J]. Pregnancy hypertension, 2020, 22: 37-46.
[27] Chen Y, Ding H, Wei M, et al. MSC-secreted exosomal H19 promotes trophoblast cell invasion and migration by downregulating let-7b and upregulating FOXO1[J]. Molecular Therapy-Nucleic Acids, 2020, 19: 1237-1249.
[28] Zhu Y, Zhang J, Hu X, et al. Extracellular vesicles derived from human adipose-derived stem cells promote the exogenous angiogenesis of fat grafts via the let-7/AGO1/VEGF signalling pathway[J]. Scientific reports, 2020, 10(1): 5313.
[29] Chu Y, Chen W, Peng W, et al. Amnion-derived mesenchymal stem cell exosomes-mediated autophagy promotes the survival of trophoblasts under hypoxia through mTOR pathway by the downregulation of EZH2[J]. Frontiers in cell and developmental biology, 2020, 8: 545852.
[30] Li Y , Wang C , Xi H M ,et al.Chorionic villus-derived mesenchymal stem cells induce E3 ligase TRIM72 expression and regulate cell behaviors through ubiquitination of p53 in trophoblasts[J].The FASEB Journal, 2021, 35.
[31] Wu D , Liu Y , Liu X X ,et al.Heme oxygenase-1 gene modified human placental mesenchymal stem cells promote placental angiogenesis and spiral artery remodeling by improving the balance of angiogenic factors in vitro[J].Placenta, 2020, 99:70-77.
[32] Robertson SA, Care AS, Moldenhauer LM. Regulatory T cells in embryo implantation and the immune response to pregnancy. J Clin Invest. 2018 Oct 1; 128(10):4224-4235. doi: 10.1172/JCI122182. Epub 2018 Oct 1. PMID: 30272581; PMCID: PMC6159994.
[33] Du W, Zhang K, Zhang S, et al. Enhanced proangiogenic potential of mesenchymal stem cell-derived exosomes stimulated by a nitric oxide releasing polymer [J]. Biomaterials, 2017, 133: 70-81.
[34] Chiang M D, Chang C Y, Shih H J, et al.Exosomes from Human Placenta Choriodecidual Membrane-Derived Mesenchymal Stem Cells Mitigate Endoplasmic Reticulum Stress, Inflammation, and Lung Injury in Lipopolysaccharide-Treated Obese Mice[J].Antioxidants (Basel, Switzerland), 2022, 11(4).
[35] Pak H, Hadizadeh A, Heirani‐Tabasi A, et al. Safety and efficacy of injection of human placenta mesenchymal stem cells derived exosomes for treatment of complex perianal fistula in non‐Crohn's cases: clinical trial phase I[J]. Journal of Gastroenterology and Hepatology, 2023, 38(4): 539-547.
[36] Clark K , Zhang S , Barthe S ,et al.Placental Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Myelin Regeneration in an Animal Model of Multiple Sclerosis[J].Cells, 2019, 8(12):1497.

Subscription

E-Mail Alert

Downloads:	4556
Visits:	197274

A Review of the Studies on Placental Mesenchymal Stem Cells and Their Exosomes Applied to Preeclampsia

Author(s)

Affiliation(s)

Corresponding Author

ABSTRACT

KEYWORDS

CITE THIS PAPER

REFERENCES

RESOURCES

JOIN US

PUBLICATION SERVICES

CONTACT US